AML

Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches
Fierce Pharma
Mon, 08/20/18 - 11:46 am
Jazz Pharmaceuticals
hirings
drug reps
solriamfetol
narcolepsy
Europe
Vyxeos
AML
AbbVie, Tolero team up to test Venclexta combo in AML
Fierce Biotech
Sat, 08/18/18 - 05:09 pm
AbbVie
Tolero Pharmaceuticals
Venclexta
alvocidib
AML
Otsuka’s $886M-plus drug just flopped in its first crucial PhIII trial for frontline AML
Endpoints
Tue, 07/31/18 - 10:14 am
Otsuka
SGI-110
clinical trials
AML
Agios scores its second new drug approval, ivosidenib heads to the AML market
Endpoints
Fri, 07/20/18 - 11:52 am
Agios Pharmaceuticals
ivosidenib (AG-120)
AML
acute myeloid leukemia
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
CP Wire
Wed, 05/2/18 - 07:21 pm
Kura Oncology
tipifarnib
patents
AML
PTCL
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
CP Wire
Wed, 05/2/18 - 10:52 am
Aptevo
FDA
APVO436
AML
myelodysplastic syndrome
Here's Why GlycoMimetics Could Become a Takeover Target
Yahoo/Motley Fool
Sun, 12/17/17 - 11:36 am
GlycoMimetics
M&A
GMI-1271
AML
acute myeloid leukemia
Pfizer
FDA Approves Pfizer’s Mylotarg 7 Years After it was Pulled From the Market
RAPS.org
Fri, 09/1/17 - 04:06 pm
Pfizer
FDA
Mylotarg
acute myeloid leukemia
AML
FDA approves Jazz Pharmaceuticals’ liposomal AML chemotherapy
Drug Delivery Business News
Tue, 08/8/17 - 10:05 am
FDA
Jazz Pharmaceuticals
liposomal chemotherapy
Vyxeos
AML
Jazz nabs early FDA nod for AML med Vyxeos. Is diversifying M&A next?
Fierce Pharma
Thu, 08/3/17 - 09:49 pm
Jazz Pharmaceuticals
FDA
AML
Vyxeos
M&A
FDA padlocks any new human tests on Seattle Genetics’ cancer drug in the wake of more deaths
Endpoints
Thu, 06/22/17 - 09:38 am
FDA
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Seattle Times, WA
Mon, 06/19/17 - 11:38 pm
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Novartis bags FDA OK for Rydapt, adding a new chemo combo drug for AML
Endpoints
Sat, 04/29/17 - 10:02 am
Novartis
FDA
Rydapt
chemotherapy
AML
acute myeloid leukemia
Seattle Genetics to resume trials as FDA lifts clinical hold
Yahoo/Reuters
Mon, 03/6/17 - 09:52 am
Seattle Genetics
clinical trials
FDA
vadastuximab talirine
AML
acute myeloid leukemia
Celgene, Agios beat a short path to an FDA decision on AML drug
Endpoints
Wed, 03/1/17 - 08:53 pm
Celgene
Agios
FDA
AML
enasidenib
acute myeloid leukemia
Seattle Genetics Initiates Phase 1 Trial of SGN-CD123A for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Yahoo
Mon, 09/19/16 - 09:51 am
Seattle Genetics
clinical trials
SGN-CD123A
AML
acute myeloid leukemia
Celator Pharmaceuticals Nabs a Key FDA Designation, Readies for 2017
Motley Fool
Thu, 05/19/16 - 10:14 pm
Celator Pharmaceuticals
FDA
Vyxeos
AML
acute myeloid leukemia
Is This the End of Sunesis?
24/7 Wall St
Fri, 07/24/15 - 06:00 pm
Sunesis
FDA
AML
vosaroxin
acute myeloid leukemia
Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML)
Yahoo
Mon, 06/1/15 - 09:58 am
Asterias
AST-VAC1
AML
acute myelogenous leukemia
Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1
Yahoo
Tue, 04/21/15 - 09:25 am
Asterias
clinical trials
AST-VAC1
vaccines
AML

Pages